Avinoam Kadouri
Corporate Officer/Principal presso Weizmann Institute of Science
Posizioni attive di Avinoam Kadouri
Società | Posizione | Inizio | Fine |
---|---|---|---|
Weizmann Institute of Science | Corporate Officer/Principal | - | - |
Storia della carriera di Avinoam Kadouri
Precedenti posizioni note di Avinoam Kadouri
Società | Posizione | Inizio | Fine |
---|---|---|---|
BONUS BIOGROUP LTD. | Direttore Tecnico/Scientifico/R&S | 04/10/1981 | 01/09/2016 |
Fondatore | 04/10/1981 | 01/09/2016 | |
The European Association for Bioindustries | Presidente | - | - |
Animal Cell Technology Industrial Platform | Presidente | - | - |
Serono International SA | Corporate Officer/Principal | - | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Direttore Tecnico/Scientifico/R&S | 28/07/2009 | - |
Corporate Officer/Principal | - | 28/07/2009 | |
Uni Targeting Research AS
Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | Direttore Tecnico/Scientifico/R&S | - | - |
Statistiche
Distribuzione geografica
Israele | 3 |
Stati Uniti | 3 |
Norvegia | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 3 |
Chairman | 2 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
BONUS BIOGROUP LTD. | Health Technology |
Aziende private | 5 |
---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Uni Targeting Research AS
Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | Health Technology |
The European Association for Bioindustries | |
Serono International SA | |
Animal Cell Technology Industrial Platform |
- Borsa valori
- Insiders
- Avinoam Kadouri
- Esperienza